These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22182264)

  • 21. Evolution and the scientific method.
    Tucker HM; Estus S
    Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?
    Klein WL; Krafft GA; Finch CE
    Trends Neurosci; 2001 Apr; 24(4):219-24. PubMed ID: 11250006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amyloid hypothesis: let sleeping dogmas lie?
    Bishop GM; Robinson SR
    Neurobiol Aging; 2002; 23(6):1101-5. PubMed ID: 12470810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular neuropathology of Alzheimer dementia and therapeutic approaches.
    Robakis NK
    Adv Exp Med Biol; 2015; 822():1. PubMed ID: 25416969
    [No Abstract]   [Full Text] [Related]  

  • 25. S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer's Disease.
    Wang C; Iashchishyn IA; Pansieri J; Nyström S; Klementieva O; Kara J; Horvath I; Moskalenko R; Rofougaran R; Gouras G; Kovacs GG; Shankar SK; Morozova-Roche LA
    Sci Rep; 2018 Aug; 8(1):12836. PubMed ID: 30150640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
    Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM
    J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    Paroni G; Bisceglia P; Seripa D
    J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice.
    Li H; Ruberu K; Muñoz SS; Jenner AM; Spiro A; Zhao H; Rassart E; Sanchez D; Ganfornina MD; Karl T; Garner B
    Neurobiol Aging; 2015 May; 36(5):1820-33. PubMed ID: 25784209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: a central role for amyloid.
    Selkoe DJ
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):438-47. PubMed ID: 8083687
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular characterization of Netrin-1 and APP receptor binding: New leads to block the progression of senile plaques in Alzheimer's disease.
    Borel F; Marzocca F; Delcros JG; Rama N; Mehlen P; Ferrer JL
    Biochem Biophys Res Commun; 2017 Jul; 488(3):466-470. PubMed ID: 28501620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?
    Nalivaeva NN; Beckett C; Belyaev ND; Turner AJ
    J Neurochem; 2012 Jan; 120 Suppl 1():167-185. PubMed ID: 22122230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of plaque formation in Alzheimer's disease.
    Urbanc B; Cruz L; Buldyrev SV; Havlin S; Irizarry MC; Stanley HE; Hyman BT
    Biophys J; 1999 Mar; 76(3):1330-4. PubMed ID: 10049316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
    Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
    Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease.
    Brohede J; Rinde M; Winblad B; Graff C
    J Neurogenet; 2010 Dec; 24(4):179-81. PubMed ID: 20919856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult.
    Rosenblum WI
    Neurobiol Aging; 2014 May; 35(5):969-74. PubMed ID: 24210593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease.
    Nunan J; Small DH
    Essays Biochem; 2002; 38():37-49. PubMed ID: 12463160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.